Johnson & Johnson to Pay $572 million in Opioid Case
[from AMA Morning Rounds]
The New
York Times (8/26, Hoffman) reports Judge Thad Balkman of Oklahoma’s
Cleveland County District Court “ruled against Johnson & Johnson...and
ordered it to pay the state $572 million in the first trial of an opioid
manufacturer for the destruction wrought by prescription” pain medications.
Oklahoma argued that the company, “which contracted with poppy growers in
Tasmania, supplied 60 percent of the opiate ingredients that drug companies
used for opioids like oxycodone,...and aggressively marketed opioids to doctors
and patients as safe and effective.” The article says the ruling “may indicate
what lies ahead in 2,000 more lawsuits.”
The Washington
Post (8/26, A1, Bernstein) reports the “decision is the first to hold a
drugmaker culpable for the fallout of years of liberal opioid dispensing that
began in the late 1990s, sparking a nationwide epidemic of overdose deaths and
addiction.”
For more information on the
AMA’s policy regarding opioid-related costs, click
here.
< Previous Article |
Next Article >
[ return to top ]
|